Views 710
Citations 0
News From the Food and Drug Administration
June 2, 2015

FDA Okays Drug to Reduce Double Chins

Author Affiliations

Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA. 2015;313(21):2115. doi:10.1001/jama.2015.5384

The drug Kybella received FDA approval in late April for treating adults with moderate-to-severe fat below the chin without surgery.

When properly injected into that area, the drug destroys fat cells. However, it can also destroy other types of cells, such as skin cells, if accidentally injected into the skin. It is neither approved nor recommended for trimming fat from any other part of the body, the FDA said in a statement.

“Treatment with Kybella should only be provided by a licensed health care professional, and patients should fully understand the risks associated with use of the drug before considering treatment,” FDA official Amy Egan, MD, MPH, said in a statement.

First Page Preview View Large
First page PDF preview
First page PDF preview